Tofacitinib in recalcitrant scleritis: First case report from India

A 65-year-old male presented with redness and pain associated with active necrotizing scleritis in the left eye. He was started on mycophenolate mofetil and oral corticosteroids, to which there was no response detected after 4 weeks. A rheumatology opinion was sought and he was started on tofacitini...

Descripción completa

Detalles Bibliográficos
Autores principales: Pyare, Richa, Kaushik, Viswanath, Dutta Majumder, Parthopratim, Biswas, Jyotirmay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690527/
https://www.ncbi.nlm.nih.gov/pubmed/32823452
http://dx.doi.org/10.4103/ijo.IJO_534_20
Descripción
Sumario:A 65-year-old male presented with redness and pain associated with active necrotizing scleritis in the left eye. He was started on mycophenolate mofetil and oral corticosteroids, to which there was no response detected after 4 weeks. A rheumatology opinion was sought and he was started on tofacitinib, after which there was dramatic clinical improvement. Patients refractory to conventional immunosuppressive therapy can benefit from the new class of immunosuppressive agents, JAK/STAT kinase inhibitors.

Ejemplares similares